Investments

Institutional investors shift to defence, expecting a volatile 2021: survey

Investors are making tactical shifts within asset classes

By Mark Burgess |December 8, 2020

2 min read

As vaccine rollouts begin, investors weigh risks and rewards of biotech sector

For the most part, Canadian investors have to turn to the U.S. to access pharmaceutical efforts to combat Covid

By Ross Marowits, The Canadian Press |December 7, 2020

4 min read

ETF inflows surpass last year with one month to go

In November, vaccine news helped drive equity indexes

By Staff |December 3, 2020

2 min read

Housing’s sizzle is set to fizzle

Outperformance won’t last, Benjamin Tal says

By Michelle Schriver |December 1, 2020

2 min read